Elizabeth Cermak - Nov 4, 2024 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
Director
Signature
/s/ Jonathan Foster by Power of Attorney
Stock symbol
MBRX
Transactions as of
Nov 4, 2024
Transactions value $
$0
Form type
4
Date filed
11/6/2024, 08:05 PM
Previous filing
May 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Stock option (right to buy) Award +10K +214.22% 14.7K Nov 4, 2024 Common Stock 10K $2.45 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options set forth in this table vest through April 2025, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
F2 The options were issued in connection with the reporting person's Board of Director service to the Company.